Trials / Completed
CompletedNCT00408421
Duloxetine Versus Placebo for Osteoarthritis Knee Pain
Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 231 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | |
| DRUG | placebo |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2006-12-07
- Last updated
- 2009-08-19
- Results posted
- 2009-08-19
Locations
27 sites across 3 countries: United States, Puerto Rico, Romania
Source: ClinicalTrials.gov record NCT00408421. Inclusion in this directory is not an endorsement.